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Purpose: To identify the genetic defect of a consanguineous Portuguese family with rod-cone dystrophy and varying
degrees of decreased audition.
Methods: A detailed ophthalmic and auditory examination was performed on a Portuguese patient with severe autosomal
recessive  rod-cone  dystrophy.  Known  genetic  defects  were  excluded  by  performing  autosomal  recessive  retinitis
pigmentosa (arRP) genotyping microarray analysis and by Sanger sequencing of the coding exons and flanking intronic
regions of eyes shut homolog–drosophila (EYS) and chromosome 2 open reading frame 71 (C2orf71). Subsequently,
genome-wide homozygosity mapping was performed in DNA samples from available family members using a 700K single
nucleotide polymorphism (SNP) microarray. Candidate genes present in the significantly large homozygous regions were
screened for mutations using Sanger sequencing.
Results: The largest homozygous region (~11 Mb) in the affected family members was mapped to chromosome 9, which
harbors deafness, autosomal recessive 31 (DFNB31; a gene previously associated with Usher syndrome). Mutation
analysis of DFNB31 in the index patient identified a novel one-base-pair deletion (c.737delC), which is predicted to lead
to a truncated protein (p.Pro246HisfsX13) and co-segregated with the disease in the family. Ophthalmic examination of
the index patient and the affected siblings showed severe rod-cone dystrophy. Pure tone audiometry revealed a moderate
hearing loss in the index patient, whereas the affected siblings were reported with more profound and early onset hearing
impairment.
Conclusions: We report a novel truncating mutation in DFNB31 associated with severe rod-cone dystrophy and varying
degrees of hearing impairment in a consanguineous family of Portuguese origin. This is the second report of DFNB31
implication in Usher type 2.
Rod-cone dystrophy, also known as retinitis pigmentosa
(RP), is a clinically and genetically heterogeneous group of
inherited disorders. In most cases, it primarily affects rod
function,  with  night  blindness  being  an  initial  symptom,
followed  by  secondary  cone  degeneration  leading  to
progressive visual-field constriction, abnormal color vision,
and eventually the loss of central vision. It is the most common
inherited form of potentially severe retinal degeneration and
blindness, with a frequency of about 1 in 4000 births and more
than 1 million affected individuals worldwide [1]. Inheritance
of  RP  can  be  either  autosomal  recessive  (ar),  autosomal
dominant  (ad)  or  X-linked  (xl)  with  rare  cases  of
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mitochondrial  transmission.  Recessive  and  isolated  cases
account for 50%–60% of all forms of RP [1], with more than
34  implicated  genes  (RetNet,  access  March  21st,  2011).
Furthermore, arRP can occur with extra-ocular symptoms as
in  Usher  syndrome,  in  which  RP  is  associated  with
neurosensory deafness [2]. It is the most common form of
syndromic RP and accounts for up to 30% of all RP cases
[3].  Three  types  of  Usher  syndrome  have  been  clinically
described, and are distinguished by variations in the severity
and progression of neurosensory deafness, the presence or
absence of vestibular abnormalities and the age of onset of the
retinal dystrophy [2]. Genetic heterogeneity also characterizes
each type and at least nine genes underlying Usher syndrome
have been identified [2,4] (Retnet, access March 21st, 2011).
To  date,  different  methods  have  been  used  to  detect
disease-causing  mutations  underlying  heterogeneous
disorders such as arRP and Usher syndrome. Direct Sanger
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1598sequencing  of  all  known  disease-causing  genes  is  labor-
intensive, time-consuming and expensive, due to the large
genetic heterogeneity and the length of some of the candidate
genes, but remains the most precise way to genotype patients.
Alternatively,  a  commercially  available  genotyping
microarray for arRP and Usher syndrome can be applied: this
uses  the  arrayed  primer  extension  (APEX)  methodology
(Asper Ophthalmics, Tartu, Estonia) [5,6] and allows for the
detection  of  known  mutations  but  fails  to  discover  novel
mutations.  Another  technique  uses  a  custom-designed
resequencing  chip  (customSEQ)  to  evaluate  all  exons  for
which a mutation had previously been reported in 19 genes
[7]. Although this technique allows the detection of novel
variants,  unscreened  regions  are  missed.  Next-generation
sequencing  approaches  of  candidate  genes  and/or  whole
exome or genome sequencing have been initiated; however,
data interpretation is complex and further studies are needed
before this technology can be used as a daily diagnostic tool.
Homozygosity mapping using high-density single nucleotide
polymorphism (SNP) microarrays in consanguineous as well
as non-consanguineous but geographically isolated families
is  an  efficient  tool  for  localizing  genetic  defects  in
homozygous regions and has proven its efficacy in identifying
novel arRP genes [8-13].
In the present study, we applied homozygosity mapping
to a consanguineous Portuguese family (which was previously
excluded for known mutations using the arRP genotyping
microarray analysis) to identify the cause of disease.
METHODS
The study protocol adhered to the tenets of the Declaration of
Helsinki and was approved by the local Ethics Committee
(CPP,  Ile  de  France  V).  Informed  written  consent  was
obtained from each of the study participants.
Clinical evaluation: The index patient underwent a full
ophthalmic  examination  featuring  the  assessment  of  best-
corrected visual acuity, kinetic and static perimetry and color
vision using 15 desaturated HUE. Full-field and multifocal
electroretinography (ERG and mfERG) were performed with
Dawson,  Trick,  Litzkow  (DTL)  recording  electrodes  and
incorporated  the  International  Society  for  Clinical
Electrophysiology of Vision (ISCEV) recommendations and
guidelines (Espion2 Diagnosys® for the full field ERG and
Veris II for the Multifocal ERG) [14,15]. Clinical assessment
was completed with fundus autofluorescence imaging (FAF)
and  optical  coherence  tomography  (OCT;  HRAII®  and
Spectralis®  OCT;  Heidelberg  Engineering,  Dossenheim,
Germany).  After  the  genetic  results  were  obtained,  a
subsequent  auditory  examination,  including  pure  tone
audiometry,  was  performed  on  the  index  patient.  Further
clinical details for the other affected family members were
obtained from their personal health records.
Molecular genetic analysis: Total genomic DNA was
extracted from peripheral blood leucocytes according to the
manufacturer’s  recommendations  (Puregen  Kit;  Qiagen,
Courtaboeuf,  France).  The  DNA  sample  from  the  index
patient  was  first  analyzed  and  excluded  for  all  known
mutations by applying microarray analysis on a commercially
available  chip  (arRP;  ASPER  Ophthalmics).  Pathogenic
variants  on  eyes  shut  homolog  –drosophila  (EYS)  and
chromosome  2  open  reading  frame  71  (C2ORF71)  were
excluded  by  directly  sequencing  the  coding  exonic  and
flanking regions of the respective genes [16,17].
DNA samples from the available family members were
subsequently  genotyped  using  a  700K  genome-wide  SNP
microarray  (Illumina  HumanOmniExpress,  München,
Germany). Genotype calling was done with GenomeStudio
software according to the protocols provided by Illumina. In
the initial analysis, 686389 SNPs passed the quality control.
The  homozygous  regions  were  mapped  using
HomozygosityMapper  [18].  Genes  located  in  the  mapped
regions were sorted using GeneDistiller. The 12 known exons
of  deafness,  autosomal  recessive  31  (DFNB31)  and  their
flanking  regions  were  PCR  amplified  in  14  fragments
(DFNB31 RefSeq NM_015404) from the DNA of the index
patient and directly sequenced according to the following
protocol: PCR reaction, using the oligonucleotide primers
indicated in Table 1, was performed from 100 ng of genomic
DNA  using  a  commercially  available  polymerase  (HOT
FIREPol DNA Polymerase; Solis BioDyne, Tartu, Estonia),
1 mM MgCl2 except exon 2, 3, and 10, for which 2.5 mM
MgCl2 was used, 0.2 mM dNTPs (Solis BioDyne), and buffer
B2  (Solis  BioDyne)  were  used  at  different  annealing
temperatures as indicated in Table 1. The PCR products were
enzymatically purified with 5 µl of a 1:50 dilution (ExoSAP-
IT; USB Corporation, Cleveland, OH purchased from GE
Healthcare, Orsay, France) at 37 °C for 15 min and the enzyme
was deactivated at 80 °C for 15 min. Then, a 0.5 µl sequencing
kit (BigDyeTerm v1.1 CycleSeq kit; Applied Biosystems,
Courtabœuf, France), 1.25 µl 5× sequencing buffer (BigDye
Sequencing buffer; Applied Biosystems) and 0.8 µl 5 µM or
10  µM  oligonucleotide  were  added  to  the  purified  PCR
products. The cycling conditions were as follows: 95 °C for
20 s, 25 times: 96 °C for 20 s, 50 °C for 10 s, and 60 °C for 2
min. The sequenced product was purified on a presoaked
(300 µl H20 for 3 h, centrifuged at 1500× g for 1 min, 150 µl
H2O centrifuged at 950× g for 5 min) Sephadex G-50 (GE
Healthcare)  96-well  multiscreen  filter  plate  (Millipore,
Molsheim, France) and eluted with an additional 10 µl of
H2O. The purified product was analyzed on an automated 48-
capillary  sequencer  (ABI  3730  Genetic  analyzer,  Applied
Biosystems) and the results were interpreted using software
(SecScape, Applied Biosystems).
The  mutation  was  described  according  to  the  HGVS
website. In accordance with this nomenclature, nucleotide
numbering reflects cDNA numbering with +1 corresponding
to  the  A  of  the  ATG  translation  initiation  codon  in  the
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1599reference  sequence.  The  initiation  codon  is  codon  1.  The
correct  nomenclature  for  the  mutation  was  verified  by
applying Mutalyzer.
RESULTS
Molecular genetics: The interpretation of the genome-wide
SNP  microarray-screening  results  identified  four
homozygous regions that were only present in the affected
subjects, with more than 80% of the maximum score (see
pedigree,  Figure  1).  The  largest  region  was  identified  on
chromosome 9q32-q33.3 and encompassed approximately 11
Mb. The three other homozygous regions were located on
chromosome  15q26.1-q26.2,  13q34  and  1p21.3,  which
revealed  lengths  of  approximately  3,  1.3  and  0.4  Mb,
respectively. Within the mapped region on chromosome 9,
102  genes  were  sorted  using  GeneDistiller,  among  which
DFNB31,  encoding  whirlin,  was  the  only  gene  already
reported to be involved in rod-cone dystrophy associated with
deafness as part of Usher syndrome type 2 (USH2D locus)
[19]. No other genes previously reported to underlie retinal
dystrophy or deafness were found in either of the homozygous
regions.  Mutation  analysis  of  DFNB31  identified  a  1-bp
deletion, which is predicted to lead to a frameshift resulting
in  a  premature  stop  codon  in  exon  2  (c.737delC;
p.Pro246HfsX13; Figure 2). Co-segregation analysis on the
available samples from the family confirmed the homozygous
change in all affected subjects and the heterozygous status of
the unaffected daughter of the index patient (Figure 1).
Clinical characteristics: The index patient was 60 years old
at  the  time  of  the  examination.  At  age  20,  she  had  been
diagnosed with RP, causing night vision difficulties, visual
field constriction and a mild decrease in visual acuity. There
was  no  other  relevant  medical  history.  Ophthalmologic
history besides the diagnosis of RP included cataract surgery
at age 47 on the right eye and at 54 on the left eye. At the time
of the examination, the best-corrected visual acuity of the
index patient was reduced to light perception for the right eye
and 20/200 for the left eye. Refraction after cataract surgery
was, for the right eye +2.5, and for the left eye +2.75. Anterior
segment  examination  was  unremarkable,  aside  from  the
bilateral  artificial  intraocular  lenses.  There  was  bilateral
vitreous detachment and there were few intravitreal cells.
Fundus examination revealed pale optic discs, narrow blood
vessels,  peripheral  pigmentary  changes  with  intraretinal
pigment migration associated with macular atrophic changes
(Figure 3A). Autofluoresence fundus images revealed a loss
of autofluorescence outside the vascular arcades as well as
loss of autofluorescence in the macular region of the right eye.
TABLE 1. OLIGONULEOTIDE PRIMER SEQUENCES USED FOR PCR AMPLIFICATION OF CODING AND FLANKING REGIONS AND DIRECT SEQUENCING.
Amplified fragment Primer sequenced (5′-3′) Annealing temperature
Exon 1; 1st fragment GGAACTCGCTGGAAGACTC 58 °C
  GTACAGTGGCTGGATCCTAG 60 °C
Exon 1; 2nd fragment CTCTTGTGTCTCTCAGGAAC 58 °C
  CACCAGGTCGAAGACGTTG 58 °C
Exon 1; 3rd fragment GGTTACTGTCTGCCAACGTG 60 °C
  AGACTCTCTCCAAACCACAG 58 °C
Exon 2 CCTTCCTCTAACCTTTGTATC 58 °C
  GAGAATACGGTGTCTGAGAG 58 °C
Exon 3 TCCCTCTAATGTTATCCTCTC 58 °C
  AAAGAGCTCCATGCACAGAG 58 °C
Exon 4 CCAGGTGACTGTATTGTGTG 58 °C
  GTCTGGAGATTGGAGCGAG 58 °C
Exon 5 GCCAACATCTAGAAAGATACC 58 °C
  CTGTGAGGAAGCAGAGAATAC 60 °C
  TCAGCTCTAGAGCAGCTAAG 58 °C
Exon 6 GGAAATGCTGAAGCCAGTTG 58 °C
Exon 7 CCTGTTCCACCTTCTAGTAG 58 °C
  GATTCGAACTCAGGCTGGTC 60 °C
Exon 8 CTCAGCTTCTGTTTGCTCAC 58 °C
  GCTGTCATGGAGAGGAGAG 58 °C
Exon 9 ACTCCTTCTCCGCCTGTTG 58 °C
  CTGGCCTTGCTGTACTCAC 58 °C
Exon 10 TATATAAGCTGCTTCTCTCTTC 58 °C
  ACCTCCCATTCTGTGCCTG 58 °C
Exon 11 GTGGTGTCCTTCCTAATACC 58 °C
  GTAGGGAGAGATGGCAAGTG 60 °C
Exon 12 AAGCCAGGCCTGTCTAACC 58 °C
  GTCCTGCTCTCTTCCTCTC 58 °C
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1600Similarly, the left eye exhibited loss of autofluorescence in
the periphery with better-preserved autofluorescence than the
right eye in the macular region (Figure 3B). OCT imaging
revealed  a  widespread  disappearance  of  the  outer  retinal
structures with a relatively better preservation of those in the
left eye than in the right (Figure 3C). These findings are
consistent with the diagnosis of severe rod-cone dystrophy
with  macular  involvement  predominant  in  the  right  eye.
Binocular Goldman visual field was below 10° with the III4
stimulus.  Both  full-field  and  multifocal  ERG  were
undetectable.
In the present study, the index patient did not mention any
hearing impairment during the initial medical questionnaire,
but her husband subsequently pointed out that she had had
more difficulties understanding him for the past few years,
suggesting  progressive  hearing  loss.  Upon  auditory
examination, the index patient reported only recent hearing
difficulties and bilateral tinnitus. There was no past history of
language  or  developmental  abnormalities.  There  was  no
reported acute noise or audio-toxic medicine exposure, nor
any history of otitis. The patient had no reported balance
Figure  1.  Co-segregation  analysis  of  DFNB31  mutation  in  the
consanguineous  Portuguese  family.  Filled  symbols  represent  the
affected  and  the  unfilled  symbols  represent  the  unaffected
individuals. Squares depict males and circles depict females. Arrows
mark the index patients. Equation symbols represent the unaffected
alleles.
problems.  Her  audioscopy  was  normal,  as  was  her
tympanometry.  Pure  tone  audiometry  revealed  bilateral
moderately severe hearing loss at −63 dB for the right ear and
−53  dB  for  the  left  ear  (Figure  4).  Hearing  aids  were
subsequently recommended.
The affected brother and sisters were living in Portugal
and  therefore  not  available  for  ophthalmic  and  auditory
examinations.  However,  they  were  reported  by  their
respective  physicians  as  having  severe  visual  impairment
comparable to that of the index patient and with a similar age
of onset. All of the affected siblings notably revealed post-
lingual hearing impairment that was more profound than in
the  index  patient.  Progressive  hearing  impairment  began
before the age of ten and they required hearing aids in their
teenage years.
DISCUSSION
Our study reporting a novel homozygous truncating mutation
in DFNB31 associated with severe rod-cone dystrophy and
variable  degrees  of  hearing  loss  in  a  consanguineous
Portuguese family provides the second report of DFNB31
involvement in Usher syndrome.
DFNB31 mutations were initially reported for the mouse
ortholog in the whirler mouse (Whrn) in autosomal recessive
nonsyndromic profound sensoryneural deafness (Deafness,
autosomal  recessive  31)  [20-22]  and  subsequently  in  one
German family with Usher type 2 syndrome [19].
Figure  2.  Sequence  chromatographs  for  the  novel  homozygous
mutation c.737delC found in exon 2 of DFNB31 of the index patient
leading to a frameshift and premature stop codon p.Pro246HfsX13
and the respective control sequence below.
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1601Figure 3. Ophthalmic phenotypic characterization of the right (OD) and left (OS) eye of the index patient. A: Color fundus photographs
showing widespread changes in the midperiphery associated with atrophic changes in the macular area. B: Fundus autofluorescence imaging
showing loss of autofluorescence in the midperiphery and in the perifoveal region. C: Sprectral domain optical coherence tomography of the
right (OD) and left (OS) macula showing perifoveal thinning of the external layer of the retina.
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1602DFNB31 encompasses 12 exons and encodes whirlin.
Whirlin is a key partner in the Usher protein network, engaged
in direct interactions with other Usher proteins [23-27]. These
findings  suggest  that  DFNB31  may  play  a  major  role  in
stereocilia  elongation,  development  and  maintenance  of
cochlear hair cells and in the ciliary transport system between
the inner and outer segment of photoreceptors [23,25,27-30].
Alternative splicing of DFNB31 results in two main whirlin
isoforms. The long isoform, encoded by exon 1 to 12, is
composed  of  two  PDZ  (Postsynaptic  density,  Disc  large,
Zo-1) domains at the N-terminus followed by a proline-rich
domain and a third PDZ at the C-terminus [21]. The short
form, encoded by exon 6 to 12, lacks PDZ1 and PDZ2 of the
N-terminus and only comprises the proline-rich domain and
PDZ3 [21]. These functional domains are critical in protein–
protein interactions within the Usher network. Interestingly,
the long isoform is only expressed in photoreceptors within
the connecting cilium, whereas both isoforms are expressed
in the inner ear [27].
To date, DFNB31 mutations were identified in only two
ar deafness families from large deafness cohort studies [21,
22] (Table 2). Similarly, DFNB31 mutations are rare in Usher
syndrome, and Ebberman and coworkers are the only group
to  report  one  family  with  two  patients  being  compound
heterozygous for DFNB31 mutations (Table 2) in 97 USH2
patients [19]. In a recent study, Aller and coworkers [31]
documented genetic DFNB31 variations in a large cohort of
149 Usher type 2, 29 Usher type 1 and six Usher type 3
unrelated patients of European decent, but could not confirm
their  pathogenic  character.  Of  note,  the  only  DFNB31
mutations reported in Usher syndrome are located within the
coding region specific to the whirlin long isoform. Patients
reported  by  Ebberman  and  coworkers  were  compound
heterozygous for a nonsense mutation in exon 1, leading to a
truncated  protein  lacking  PDZ1  and  the  downstream  C-
terminal (Table 2) and for one splice site mutation resulting
in an in-frame skipping of exon 2 and fusion of PDZ1 and
PDZ2 [19]. Similarly, the novel change we report here (c.
737delC; p.Pro246HfsX13) is also located within the whirlin
long isoform and is predicted to result in a premature stop
codon, which may lead to a truncated protein lacking PDZ2
and  the  rest  of  the  C-terminal  part  of  the  long  isoform.
Alternatively, the mutation could lead to nonsense-mediated
decay of the resulting mRNA and reveal a complete loss of
the protein [32]. With these mutations affecting exon 1 or 2,
the  short  isoform  expression  would  be  unaffected.
Conversely, DFNB31 mutations reported in ar non-syndromic
deafness are truncating mutations located in exon 10 [21] and
11 [22], encoding both the long and short isoforms and can
result in protein truncation missing both the PDZ3 and the
downstream  C-terminus.  Our  finding  reinforces  the
phenotype/genotype  correlation  in  DFNB31  mutations:
mutations  affecting  PDZ1  and  PDZ2,  specific  of  the  long
isoform, lead to Usher syndrome consistent with a major role
of  these  domains  in  the  retina  [27].  Mutations  affecting
PDZ3 present on both isoforms, lead to ar non-syndromic
severe deafness, suggesting little, if any, role of this functional
domain  in  photoreceptor  function  and  maintenance.
Consequently,  one  faster  screening  strategy  that  could  be
proposed to investigate DFNB31 implication in large cohorts
of Usher patients would be to sequence only the exons that are
specific for coding the long isoform, namely 1 to 5, while
studying large cohorts of non-syndromic deafness patients to
sequence  only  exons  6  to  12.  However,  this  screening
approach still requires confirmation in ar deafness and Usher
cohorts with DFNB31 mutations.
Ophthalmic  examination  of  the  index  patient  showed
severe  rod-cone  dystrophy  with  macular  involvement.
Compared with the two affected siblings (ages 30 and 41 at
the time of examination) that were studied by Eberman and
coworkers [19], our patient had more severe retinal dystrophy,
but her older age (60 at the time of examination) might explain
the more advanced disease. In terms of audition, our index
patient  reported  late-onset  hearing  impairment  with
moderately severe hearing loss on examination, which was
not  detected  before  genetic  diagnosis.  This  suggests  that
auditory tests are critical while investigating arRP patients and
should be encouraged as part of their clinical assessment. The
Figure 4. Pure tone audiometry of the
right (RE) and left (LE) ears showing
bilateral moderately severe hearing loss
at −63 dB for the RE and −53 dB for the
LE.  (○-)  right  and  (x)  left  ear  air
conduction audiometry; (]- - -) right and
([-  -  -  -)  left  ear  bone  conduction
audiometry.
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1603auditory phenotype of our index patient is milder than the one
reported by Eberman and coworkers [19]. Although we could
not examine the other Portuguese siblings, they reported more
severe  and  early-onset,  but  post-lingual,  deafness.  This
suggests phenotypic variability in hearing impairment in this
family with DFNB31 mutation. Alternatively, the differences
in  hearing  impairment  could  be  due  to  additional  genetic
defects that are distinct from DFNB31, which are only carried
by the siblings and not by the index patient. In any case, our
family and the one reported by Eberman and coworkers [19]
differ  from  the  profound  pre-lingual  hearing  impairment
reported earlier in ar non-syndromic deafness associated with
DFNB31 mutations disrupting PDZ3, thereby underlining the
functional importance of this domain in cochlear hair cells
[20-22].
Furthermore,  our  study  reinforced  the  power  of
homozygosity  mapping  to  identify  genetic  defects  in
consanguineous  families  in  an  unbiased  way.  The  cost
efficiency of this method should be assessed in comparison
with  systematic  candidate  gene  or  mutation  microarray
screening strategies, but this should be the method of choice
for studying cases that deal with consanguineous families or
geographically  isolated  populations  in  genetically
heterogeneous  disorders  such  as  retinal  dystrophies.
Additionally,  this  strategy  increases  the  chances  of
recognizing novel phenotype/genotype associations.
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